Renal function and risk for cardiovascular events in type 2 diabetic patients with hypertension: the RENAAL and LIFE studies — Wouter B.A. Eijkelkamp (2007) | RDL Network
Renal function and risk for cardiovascular events in type 2 diabetic patients with hypertension: the RENAAL and LIFE studies
Article 2007 en
Authors
WE
Wouter B.A. Eijkelkamp
ZZ
Zhongxin Zhang
BB
Barry M. Brenner
Abstract
1 min read
A progressively higher risk for the composite cardiovascular endpoint was observed with incremental baseline serum creatinine in type 2 diabetic patients with hypertension, even within the normal range. Thus, there appears to be no serum creatinine threshold level for an increased cardiovascular risk. Baseline serum creatinine was a major independent risk factor for cardiovascular disease (www.ClinicalTrials.gov number NCT00308347).
Hans‐Henrik Parving, Dick de Zeeuw, Mark E. Cooper, Giuseppe Remuzzi, Nancy Liu, Jared Lunceford, Shahnaz Shahinfar, Peggy H. Wong, Paulette A. Lyle, Peter Rossing, Barry M. Brenner
William F. Keane, Zhongxin Zhang, Paulette A. Lyle, Mark E. Cooper, Dick de Zeeuw, Jean-Pierre Grunfeld, James P. Lash, Janet B. McGill, William E. Mitch, Giuseppe Remuzzi, Shahnaz Shahinfar, Steven Snapinn, Robert D. Toto, Barry M. Brenner
Dick de Zeeuw, Giuseppe Remuzzi, Hans‐Henrik Parving, William F. Keane, Zhongxin Zhang, Shahnaz Shahinfar, Steve Snapinn, Mark E. Cooper, William E. Mitch, Barry M. Brenner
Barry M. Brenner, Mark E. Cooper, Dick de Zeeuw, Jean‐Pierre Grünfeld, William F. Keane, Kiyoshi Kurokawa, Janet B. McGill, William E. Mitch, Hans Henrik Parving, Giuseppe Remuzzi, Arthur Barcelos Ribeiro, Mark Schluchter, Duane Snavely, Zhongxin Zhang, Roger L. Simpson, Denise Ramjit, Shahnaz Shahinfar, RENAAL Study Investigators
Discussion(0)
No comments yet. Be the first to comment.